10-69415051-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001057.3(TACR2):c.481G>A(p.Ala161Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,613,776 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A161S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001057.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001057.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.00115 AC: 175AN: 152180Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00118 AC: 296AN: 251244 AF XY: 0.00125 show subpopulations
GnomAD4 exome AF: 0.00118 AC: 1722AN: 1461478Hom.: 4 Cov.: 32 AF XY: 0.00119 AC XY: 865AN XY: 727058 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00115 AC: 175AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.00111 AC XY: 83AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at